Zuclopenthixol Ong-Acting Im Injection (Depot) 200 mg/mL, 500 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Long-acting IM Injection (Depot)

Available Strengths: 200 mg/mL, 500 mg/mL

Reference Brands: Clopixol Depot®(US)

Category: Antipsychotropic Drugs

Zuclopenthixol is a typical antipsychotic that works by blocking dopamine (D2) receptors in the brain, reducing psychotic symptoms. It’s primarily used as a long-acting intramuscular injection to manage schizophrenia, particularly in patients with poor medication compliance. It helps maintain symptom control over extended periods.

Product Description: Zuclopenthixol long-acting IM injection, a typical antipsychotic depot formulation, is not FDA-approved in the United States but is widely authorized in the EU under the brand Clopixol Depot. In Europe, it follows EMA guidelines for long-acting injectable neuroleptics, indicated for schizophrenia and related psychoses. EU compliance requires GMP manufacturing, stability data, and pharmacovigilance alignment. U.S. market entry may involve a 505(b)(2) pathway and complete ANDA dossier. To explore dossier-ready forms, formulations, and global suppliers of Zuclopenthixol long-acting IM injection, visit Pharmatradz.com.